Spinal Discs

Spinal Discs (Intervertebral Discs): A Comprehensive Reference

Overview and Definition

Intervertebral discs are fibrocartilaginous structures located between the bodies of adjacent vertebrae. They form a fibrocartilaginous joint between the vertebral bodies, linking them together. Each disc forms a fibrocartilaginous joint (a symphysis), to allow slight movement of the vertebrae, to act as a ligament to hold the vertebrae together, and to function as a shock absorber for the spine.

Collectively, the discs contribute up to one-third of the length of the vertebral column, forming an interpose between adjacent vertebrae from the axis (C2) to the sacrum. There are 23 intervertebral discs in total: 6 cervical, 12 thoracic, and 5 lumbar. They are approximately 7–10 mm thick and 4 cm in diameter (anterior–posterior plane) in the lumbar region of the spine.

The intervertebral disc should not be thought of as a homogeneous and static structure; it has a heterogeneous composition and responds dynamically to applied loads.

Anatomy and Components

Nucleus Pulposus

The nucleus pulposus is the inner layer of the intervertebral disc, made up of a gel-like substance that helps distribute pressure across the disc. It is primarily composed of water, collagen, and proteoglycans, which help give it its elastic properties. The nucleus pulposus of the disc is made of fibrocartilage, but it contains much more water than collagen and proteoglycan proteins. Its increased water content makes the nucleus pulposus more flexible and malleable to provide increased flexibility to the intervertebral disc.

The nucleus pulposus of the disc functions to distribute hydraulic pressure in all directions within the disc space, allowing even load transmission across the vertebral endplates.

Proteoglycans within the nucleus attract and retain water, ensuring the disc remains hydrated and able to resist force.

Annulus Fibrosus

The annulus fibrosus is the tough outer layer that surrounds the nucleus pulposus, providing structural integrity to the intervertebral disc. It is composed of 15 to 25 concentric fibrocartilaginous sheets known as lamellae, each arranged in alternating directions. This unique configuration enables the annulus to resist tensile forces while maintaining flexibility. The annulus primarily contains type I and type II collagen, providing strong yet elastic properties.

The anulus fibrosus consists of several layers (laminae) of fibrocartilage made up of both type I and type II collagen. Type I is concentrated toward the edge of the ring, where it provides greater strength.

Vertebral Endplates

The vertebral endplate is a thin layer of hyaline cartilage that separates the intervertebral disc from the adjacent vertebral bodies. The endplate is the third morphologically distinct part of the intervertebral disc. It is a thin horizontal layer, usually less than 1 mm thick. This structure interfaces the disc and the vertebral body. Collagen fibres within it run horizontally and parallel to the vertebral bodies, and become continuous with the disc.

Aggrecan is a cartilage-specific proteoglycan in the cartilage matrix and synovial fluid, which consists of the glycosaminoglycans (GAG) hyaluronic acid, and keratan- and chondroitin-sulfate. GAGs are essential for absorbing and storing large volumes of water in the nucleus pulposus of the IVD, and thus function as shock absorbers.

Vascular Supply and Innervation

The intervertebral discs, like other cartilages, have no blood supply. They form the largest structures in the body without their own blood vessels. During embryonic development, and at birth, they possess some vascular supply which terminates in their endplates and anulus fibrosus. However, those blood vessels quickly deteriorate leaving them with no direct blood supply during postnatal life and in adulthood. The nutrients they require are absorbed from circulating blood by means of osmosis.

The answer to disc nutrition lies in diffusion. Nutrients like glucose and oxygen diffuse from capillaries located at the disc margins, traversing the extracellular matrix to reach the inner cells.

The intervertebral disc is innervated through the sinovertebral nerves.

Regional Variation

The intervertebral discs exhibit several physiologic variations based on their location within the spine. Generally, disc thickness increases near the front and tail parts of the body, with a slight decrease at the T3–T4 level. The cervical and lumbar discs tend to have the highest ratio of disc thickness to vertebral body height, correlating with the greater range of motion observed in these regions.

Physiological Functions

Shock Absorption

The intervertebral discs play a crucial role in maintaining spinal integrity and facilitating movement. They serve as primary shock absorbers for the spine, reducing the impact of mechanical stress during everyday activities such as walking, running, and bending.

Load Bearing and Mechanical Transmission

The complex morphology and ultrastructure of the intervertebral disc of the lumbar spine in the human provide the critical elements that permit normal mobility and transmission of force through the vertebral column. The gel matrix of the intervertebral disc allows the vertebral bodies to move relative to one another while the collagen fibers anchor the vertebrae and maintain the alignment of the spinal column.

Spinal Flexibility and Range of Motion

Each intervertebral disc forms a symphysis, or a cartilaginous joint made of fibrocartilage, between two adjoining vertebrae. A symphysis is classified functionally as an amphiarthrosis, a semi-flexible joint that is more flexible than an immovable synarthrosis, but less flexible than a freely moving synovial joint.

The fluid space is important in the nutrition of the disc, showing plastic deformation and recovery characteristics. The structural elements, both macroscopically and microscopically, together with the biochemical elements, are intimately related to function.

Assessment of Spinal Disc Health

Clinical Evaluation

Clinical evaluation of disc-related pathology typically involves a comprehensive history, neurological examination, and functional assessment. The diagnostic power of clinical parameters in the diagnosis of lumbar disc herniation in patients with monoradicular pain has been evaluated in prospective studies. The level of the disc herniation was correctly predicted in 93% of cases by the location of the pain alone or supplemented by neurological signs. Apart from radicularly distributed pain, all parameters in the present literature had no or low diagnostic accuracy. Thus, in patients with monoradicular sciatica, further clinical parameters do not add to the diagnosis of lumbar disc herniation.

Studies have shown no significant association between the clinical symptoms of pain and disability and the MRI findings for the anatomical gradation of lateral spinal stenosis, the magnitude of posterior disc height, and the extent of disc degeneration. A comprehensive clinical evaluation remains essential for an accurate diagnosis, emphasizing the necessity of appropriately correlating MRI findings with their clinical significance.

Imaging

With magnetic resonance imaging and computed tomography, there now are two excellent diagnostic imaging modalities to detect noninvasively the presence of lumbar disc abnormalities and to follow the natural history of pathologic changes of a disc, with or without therapeutic interventions.

MRI grading systems assess the degree of disc degeneration based on MRI findings, focusing on disc structure, distinction between nucleus and annulus, signal intensity, and disc height. Standard grading scales range from Grade I (normal disc structure with high signal intensity) to Grade V (severe degeneration with collapsed disc space).

Functional Outcome Measures

Cross-sectional clinical studies evaluate disc health using tools such as the Oswestry Disability Index (ODI) and Visual Analogue Scale (VAS), while MRI is assessed qualitatively for the anatomical gradation of lateral spinal stenosis, the magnitude of posterior disc height, and the extent of disc degeneration.

Factors Supporting Normal Disc Function

Physical Activity and Exercise

Exercise has received increasing attention as a modifiable factor in disc health. Chronic running exercise in men and women is associated with better IVD composition (hydration and proteoglycan content) and with IVD hypertrophy. Quantitative assessment of physical activity finds that accelerations at fast walking and slow running (2 m/s), but not high-impact tasks, lower intensity walking, or static positions, correlated to positive IVD characteristics. These findings represent the first evidence in humans that exercise can be beneficial for the IVD and provide support for the notion that specific exercise protocols may improve IVD material properties in the spine.

Loading types more likely to damage lumbar IVD tissue in humans include flexion of the spine with compression, torsion, or damage to the vertebral end-plate via axial compression with subsequent IVD degeneration. While this information can inform what activities people should avoid to preserve IVD integrity, it does not inform us on exercise or habitual physical activity to "strengthen" the IVD.

Disc Nutrition via Diffusion

Engaging in regular, moderate exercise promotes mechanical loading, enhancing nutrient diffusion through the discs. Since discs are avascular, their reliance on diffusion for nutrition makes hydration and cyclic mechanical loading critical for maintaining cellular viability.

Smoking Cessation

Quitting smoking can improve vascular health, ensuring better nutrient delivery to spinal structures. Acquired factors such as obesity, diabetes mellitus, smoking, physical loading, and bone mineral density were found to be associated with disc degeneration in the literature.

Conditions and Pathologies Associated with Spinal Discs

Intervertebral Disc Degeneration (IDD)

Intervertebral disc (IVD) degeneration is a naturally occurring process that is a consequence of biological ageing and exposure to normal physiological loading over a lifetime and is characterized by loss of IVD tissue structural integrity. The nucleus pulposus changes with loss of pressurization, decreased collagen concentration, and loss of distinction from annulus fibrosus. The annulus fibrosus and cartilaginous endplate suffer delamination, tears, fractures, and clefts of their respective extracellular matrix at both microscopic and macroscopic scales. This loss of structural integrity generally follows a predictable pattern of degeneration, and it predisposes the IVD to pathological states.

IDD results from many factors, including genetic factors, aging, mechanical injury, malnutrition, and others. The pathological changes of IDD are mainly composed of the senescence and apoptosis of nucleus pulposus cells (NPCs), the progressive degeneration of extracellular matrix (ECM), the fibrosis of annulus fibrosus (AF), and the inflammatory response.

Disc Herniation

As the disc degenerates, the likelihood of functional failure to protect the neural elements and/or to provide stable spine motion and support increases. Functional failure takes the degenerated IVD to a state of disc pathology that has various phenotypes: the most common forms are disc herniation, mechanical instability, spinal stenosis, degenerative spondylolisthesis, and degenerative scoliosis.

Cellular biology research suggests that it is highly probable that mechanical overload can lead to herniation by inducing proinflammatory responses.

Spinal Stenosis and Related Complications

IDD structural changes lead to abnormal stress distribution of the spine, with subsequent biomechanical compensation resulting in a variety of potential complications, such as intervertebral space stenosis, intervertebral foramina stenosis, nerve entrapment and irritation, chronic low back pain, herniation, osteophytosis, spondylolisthesis, and spondylosis.

Degenerative Disc Disease (DDD)

Intervertebral disc degeneration (IDD) causes a variety of signs and symptoms, such as low back pain (LBP), intervertebral disc herniation, and spinal stenosis, which contribute to high social and economic costs. At present, IDD can be treated by conservative treatment and surgical treatment based on patients' symptoms.

The commonly used conservative treatments are nonsteroidal anti-inflammatory drugs and analgesics; however, the vast majority of patients need surgery to relieve symptoms, although the effect of surgery on patients with multisegment degeneration is not satisfactory. In addition, the recurrence rate after surgery is high, leading to problems such as degeneration of the adjacent segment IVD.

Risk Factors

Diabetes, obesity, and cigarette smoking are each significantly associated with an increased diagnosis of lumbar degenerative disc disease. The combination of smoking and obesity has a synergistic effect on increased rates of lumbar degenerative disc disease.

A systematic review on genetic predisposition to disc degeneration found that genes play the main role in the occurrence of disc degeneration, and that environmental factors have less importance. Obesity, occupation, smoking status, diabetes, and alcohol consumption were described as aggravating factors.

There are also studies investigating the relationship between atherosclerosis and disc degeneration. Disruption of the blood supply due to atherosclerosis contributes to the degeneration process.

Inflammatory Mechanisms

The main factors causing intervertebral disc degeneration include the destruction of the extracellular matrix (ECM), changes in IVD cell phenotypes, and the progressive inflammatory response in the IVD. Pro-inflammatory cytokines including TNF-α and IL-1β have been identified as playing pivotal roles in the degenerative cascade.

Nutrients and Natural Substances Studied for Spinal Disc Health

Given the avascular nature of intervertebral discs, systemic nutrition and targeted supplementation have attracted scientific and traditional interest. The following substances are reviewed separately for their traditional use context and the available scientific evidence.

Collagen

Structural Role: The rationale for using a specific mix of nutritional supplements including collagen hydrolysate (including collagen type II), mucopolysaccharides, hyaluronic acid, n-acetyl-glucosamine, bamboo extract, L-lysine, and vitamin C is the assumption that combining naturally occurring ingredients of the IVD would maintain spine function. Collagen, a fibrous structural protein of the connective tissue, strengthens the tendons and skeletal muscles as well as the ligaments supporting the vertebral column. The amino acids proline (non-essential) and lysine (essential) as well as ascorbic acid (vitamin C) are involved in collagen synthesis.

Scientific Evidence: A double-blinded, placebo-controlled randomized trial aimed to evaluate the efficacy of a nutraceutical supplement mix — including collagen type II, hyaluronic acid, n-acetyl-glucosamine, bamboo extract, L-lysine, and vitamin C — in the management of lumbar osteochondrosis. Fifty patients were randomly assigned to either the supplement or placebo group in a 1:1 ratio. This represents one of the few placebo-controlled trials targeting disc-specific supplementation, though its small sample size limits generalizability.

Glucosamine and Chondroitin Sulfate

Traditional/Historical Use: Glucosamine and chondroitin sulfate have long been used in complementary and integrative medicine for joint and cartilage conditions. In a CDC report on complementary and alternative medicine use among adults, low back pain was identified as the most common condition for which patients sought alternative treatments. Among adults using a non-vitamin, non-mineral supplement, 15% were using glucosamine, with over 5 million respondents using glucosamine within a previous 12-month period.

Proposed Mechanism: Glucosamine is a naturally occurring compound involved in the production of glycosaminoglycans, the proteoglycans that work alongside collagen to maintain disc hydration and structure.

Scientific Evidence: A case report suggests that long-term glucosamine and chondroitin sulfate intake may counteract symptomatic spinal disc degeneration, particularly at an early stage. However, definite proof requires well-conducted clinical trials. Most trials were on osteoarthritis of the knee, while virtually no documentation exists on spinal disc degeneration. Inconsistency exists in the literature due to variability in study design, patient inclusion, and glucosamine formulation. The GAIT trial failed to demonstrate improvement in pain and function related to knee osteoarthritis in two-year follow-up. Evidence for disc-specific effects remains very limited; the bulk of human clinical evidence derives from osteoarthritis of peripheral joints, not the spine.

A 2025 systematic review concluded that glucosamine and chondroitin are generally effective and well-tolerated, particularly for managing osteoarthritis and joint pain. Consistent dosing strategies and favorable safety profiles across a diverse range of studies support their continued use in clinical practice, but further research is needed related to other disease states.

A 2010 meta-analysis published in the BMJ arrived at the conclusion that, compared with placebo, glucosamine, chondroitin, and their combination do not reduce joint pain or affect the narrowing of joint space. In a subsequent discussion the editors of the BMJ concluded that, while they still supported the overall results of the study, they no longer accepted the specific conclusions that glucosamine and chondroitin should not be recommended by health authorities or covered by health insurers, stating that these claims "were not directly supported by the authors' data."

Vitamin D

Scientific Evidence: Known to be involved in bone-cartilage metabolism, Vitamin D may play a role in human disc pathophysiology. Given that postmenopausal women are prone to suffer Vitamin D deficiency and intervertebral disc degeneration, one study investigated whether VD can delay IDD in ovariectomized rats by improving bone microstructure and antioxidant stress. After a 6-month intervention, imaging and pathology slice examinations showed that IDD induced by ovariectomy was significantly alleviated in the vitamin D supplementation group and deteriorated by vitamin D deficiency. The expressions of aggrecan and Collagen II in intervertebral disc were reduced by ovariectomy and VD deficiency, and elevated by VD supplementation.

In vivo, compared with the control group, mice in the vitamin D group showed dose-dependent retardation of intervertebral disc degeneration in terms of reducing inflammatory responses, antioxidant stress, inhibiting apoptosis, and delaying cell aging. This was mainly due to the inhibitory effect of vitamin D on NF-κB signaling pathways. These findings are from animal studies; robust, prospective human clinical trials specifically on disc-level outcomes remain limited.

Vitamin C (Ascorbic Acid)

Biochemical Role: The amino acids proline (non-essential) and lysine (essential) as well as ascorbic acid (vitamin C) are involved in collagen synthesis. Beyond vitamin C's essential role in proline and lysine hydroxylase, it also has an anti-oxidative capacity.

Scientific Evidence: A study including data from more than 4,700 individuals reported associations between vitamin C and spinal pain. The mechanistic basis — as a rate-limiting cofactor in collagen cross-linking — is well-established biochemically, though dedicated randomized controlled trials targeting disc health specifically are lacking.

Omega-3 Fatty Acids

Scientific Evidence: Preclinical research published in Medical Science Monitor demonstrated that omega-3 supplementation reduced systemic inflammatory markers and attenuated disc dehydration and histologic signs of degeneration in an experimental model. While human disc-specific trials are limited, the anti-inflammatory mechanism is well established and omega-3s are generally well-tolerated. Evidence in humans is extrapolated primarily from anti-inflammatory mechanism research and studies on related musculoskeletal conditions; disc-specific randomized controlled trials are absent.

Curcumin (Turmeric)

Traditional Use: Boswellia oleo-gum resin and turmeric rhizomes have been widely used in Ayurveda for the treatment of inflammatory diseases and pain management.

Scientific Evidence: A rat study investigated whether curcumin can alleviate lumbar intervertebral disc degeneration (LIDD) through regulating the expression of iNOS, COX-2, TGF-β1/2, MMP-9, and BDNF. The results suggest that pretreatment with curcumin can prevent the development of LIDD in rats. Treatment with curcumin significantly reduced interleukin (IL)-1β and IL-6, iNOS, COX-2, and MMP-9 levels in rats with LIDD. The findings indicate that curcumin may exert protective effects on LIDD development, exerting its action through the regulation of iNOS, COX-2, TGF-β1/2, MMP-9, and BDNF.

This evidence is entirely preclinical (animal/in vitro). No direct randomized controlled trials on curcumin specifically for intervertebral disc degeneration in humans were identified in PubMed as of the time of this writing.

Boswellia serrata

Traditional Use: Boswellia serrata is a botanical commonly used in Ayurveda for minor aches and pains. The main bioactive constituents of boswellia are boswellic acids. Boswellia serrata extracts are often standardized to the 3-O-acetyl-11-keto-beta-boswellic acid (AKBA).

Scientific Evidence: Human clinical evidence for Boswellia in the context of disc-related conditions is emerging but largely derived from osteoarthritis trials. The synergistic effects of curcumin and boswellia extract in alleviating pain and inflammation in osteoarthritic participants have been reported. A previous study reported the effects of a curcumin and Boswellia combination at 500 mg × 3/day during a 12-week study period. Rigorous clinical evidence on the effectiveness, cost-effectiveness, and safety of individual traditional medicine therapies for disc-related conditions remains insufficient. Evidence for Boswellia specifically targeting intervertebral disc tissue — as opposed to general musculoskeletal pain — is preliminary.

Willow Bark (Salix alba)

Traditional Use: Willow bark has been used for therapeutic purposes for centuries, dating back more than 4,000 years with Sumerians, Babylonians, and ancient Greeks using this botanical to treat common ailments. Its main bioactive constituent, salicin, is metabolized in the body into salicylic acid. In addition to salicylates, willow bark also has polyphenols, including flavonoids, proanthocyanidins, and tannins that are thought to contribute to its biological activity.

Scientific Evidence: In a randomized double-blind study, willow bark was demonstrated to be effective at relieving back pain. After four weeks, 39% of the high-salicin group (n=65) were pain-free, 21% of the low-salicin group (n=67) were pain-free, and only 6% of the placebo group (n=59) were pain-free. This evidence pertains to general back pain symptom relief; it does not demonstrate structural modification of disc tissue.

Hyaluronic Acid

Proposed Mechanism and Research Context: Aggrecan, which includes the glycosaminoglycan hyaluronic acid, is essential for the proteoglycan function of the IVD matrix. Numerous studies have demonstrated that oral administration of collagen hydrolysate and the GAGs hyaluronic acid and glucosamine are able to reduce articular pain in the knee, providing a mechanistic rationale for investigation in disc-related conditions. Disc-specific human clinical evidence for oral hyaluronic acid remains very limited.

Evidence Strength Summary

• Exercise (moderate impact, running/walking): Evidence from human observational and cross-sectional studies (Belavý et al., Scientific Reports, 2017) demonstrating improved IVD hydration and proteoglycan content. Considered preliminary but the strongest lifestyle-level human evidence available.
• Vitamin D: Positive findings in animal models (mice, ovariectomized rats); mechanistic plausibility strong; human disc-specific RCT data lacking.
• Curcumin: Primarily preclinical (rat/cell models); no disc-specific human RCTs identified.
• Omega-3 fatty acids: Preclinical evidence; anti-inflammatory mechanism well-established; human disc-specific trials absent.
• Glucosamine/Chondroitin: Mixed evidence in osteoarthritis RCTs; one case report for disc degeneration; systematic reviews show conflicting results; disc-specific evidence very limited.
• Collagen supplements: Mechanistically plausible; one small RCT (n=50) in lumbar osteochondrosis; evidence considered preliminary.
• Willow bark: One RCT for back pain symptoms (not structural disc outcomes); traditional use well-documented.
• Boswellia: Clinical trials for musculoskeletal pain and osteoarthritis; disc-specific human data preliminary.
• Vitamin C: Essential biochemical cofactor for collagen; epidemiological associations with spinal pain; no disc-specific RCTs.

References

• PubMed — Human intervertebral disc: structure and function (1988 Review)
• Kenhub — Intervertebral discs: Anatomy, structure and function
• Wikipedia — Intervertebral disc
• JOSPT — Structure and Function of the Lumbar Intervertebral Disk in Health, Aging, and Pathologic Conditions
• PubMed — Treatment of Intervertebral Disc Degeneration (2022)
• Nature Reviews Disease Primers — Intervertebral disc degeneration (2026)
• PMC — Understanding the etiopathogenesis of lumbar intervertebral disc herniation
• PMC — Recent Advances in Managing Spinal Intervertebral Discs Degeneration
• PMC — Application and development of hydrogel biomaterials for the treatment of intervertebral disc degeneration
• PMC / Scientific Reports — Running exercise strengthens the intervertebral disc (2017)
• PubMed — Running exercise strengthens the intervertebral disc (2017)
• PMC — The Clinical Correlations between Diabetes, Cigarette Smoking and Obesity on Intervertebral Degenerative Disc Disease
• PMC — Risk Factors of Intervertebral Disc Pathology — A Review
• PMC — Smoking and degenerative spinal disease: A systematic review
• PMC — Investigating the role of DNA damage in tobacco smoking-induced spine degeneration
• PMC — Effects of Tobacco Smoking on the Degeneration of the Intervertebral Disc: A Finite Element Study
• Nutrients — A Dietary Supplement in the Management of Patients with Lumbar Osteochondrosis: A Randomized, Double-Blinded, Placebo-Controlled Study (2024)
• PMC — Vitamin D retards intervertebral disc degeneration through inactivation of the NF-κB pathway in mice
• PubMed — Vitamin D delays intervertebral disc degeneration and improves bone quality in ovariectomized rats (2024)
• PubMed — Neuroprotective effects of curcumin alleviate lumbar intervertebral disc degeneration in a rat model
• PMC — Glucosamine Supplementation Demonstrates a Negative Effect on Intervertebral Disc Matrix in an Animal Model of Disc Degeneration
• PubMed — Glucosamine and chondroitin sulfate supplementation to treat symptomatic disc degeneration: biochemical rationale and case report (2003)
• PMC — The Safety and Efficacy of Glucosamine and/or Chondroitin in Humans: A Systematic Review (2025)
• Wikipedia — Clinical trials on glucosamine and chondroitin
• NCBI Bookshelf (DARE) — Efficacy of glucosamine, chondroitin, and methylsulfonylmethane for spinal degenerative joint disease and degenerative disc disease: a systematic review
• PMC — Boswellia serrata, A Potential Anti-inflammatory Agent: An Overview
• PMC — A full-spectrum Boswellia serrata extract and its co-delivered system with curcumin alleviate pain and stiffness associated with moderate spondylitis: a randomized double-blind, placebo-controlled study
• PMC — Comparative effectiveness and safety of herbal medicine therapy for low back pain and radiculopathy caused by lumbar intervertebral disc herniation: study protocol for a pragmatic RCT
• PubMed — A critical assessment of clinical diagnosis of disc herniation in patients with monoradicular sciatica
• PubMed — The radiologic assessment for a lumbar disc herniation
• PMC — Lateral Lumbar Spinal Stenosis: Associations With the Oswestry Disability Index, Visual Analogue Scale, and MRI
• PMC — Intervertebral Disc Degeneration and Regeneration: New Molecular Mechanisms and Therapeutics